ClinConnect ClinConnect Logo
Search / Trial NCT02217696

Prediction and Intervention in Developmental Dyslexia

Launched by UNIVERSITY OF ZURICH · Aug 13, 2014

Trial Information

Current as of May 15, 2025

Unknown status

Keywords

Electroencephalography (Eeg) Magnetic Resonance Imaging (Mri) Multimodal Neuroimaging Development Prediction Intervention

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria for all groups:
  • Healthy, native (CH-) German speaking subjects, with an estimated non-verbal intelligence quotient (IQ) \>=80, without neurological and/or psychiatric disorder (except for attention deficit hyperactivity disorder, specific learning disorders, developmental language impairments)
  • * Additional criteria for subgroups:
  • * Recruitment of preschoolers (aged 5.5-7.5 years):
  • Healthy children with increased risk for developmental dyslexia in their second year at kindergarten
  • * Recruitment of children in first grade (aged 6.5-8.5years):
  • Children showing impairments in learning to read (first/second grade).
  • * Adults (aged 20-40 years):
  • Healthy, normal reading
  • Exclusion Criteria for all groups:
  • MRI contraindications
  • No history of premature delivery and/or maternal reports of severe prenatal, perinatal or postnatal complications.

About University Of Zurich

The University of Zurich, a leading institution in research and education, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust framework for conducting high-quality research, the university collaborates with multidisciplinary teams of experts to explore cutting-edge therapeutic approaches and interventions. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the utmost integrity, aiming to contribute valuable insights to the medical community and enhance health outcomes globally.

Locations

Zurich, , Switzerland

Patients applied

0 patients applied

Trial Officials

Silvia Brem, PhD

Principal Investigator

University Clinics for Child and Adolescent Psychiatry, University of Zurich

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials